Business in the Burbs

Barr Laboratories applies to make generic Thalomid

December

Barr Laboratories Inc., which has a production plant in Pomona, said today that it is seeking approval from the U.S. Food and Drug Administration to produce a generic version of Celgene Corp.Ã¢â‚¬â„¢s Thalomid capsules in 200 mg form.

Thalomid, which treats a form of leprosy, is a form of thalidomide.

Celgene said it would challenge BarrÃ¢â‚¬â„¢s application as an infringement of its Thalomid patent.

Celgene stock fell 2 percent to close at $56.35. Shares of Barr gained 30 cents, closing at $51.10.

This entry was posted on Wednesday, December 13th, 2006 at 7:14 pm by Jerry Gleeson. You can follow any responses to this entry through the RSS 2.0 feed.
Category: New products

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.